Carillon Tower Advisers’s PetMed Express PETS Stock Holding History

Carillon Tower Advisers’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$2.29M	Sell	71,413 -3,500	-5%	-$108K	0.01%	458
2020 Q3	$2.37M	Buy	74,913 +7,349	+11%	+$243K	0.03%	403
2020 Q2	$2.41M	Sell	67,564 -1,400	-2%	-$48.6K	0.02%	426
2020 Q1	$1.99M	Sell	68,964 -7,100	-9%	-$186K	0.02%	407
2019 Q4	$1.79M	Sell	76,064 -2,500	-3%	-$56K	0.01%	460
2019 Q3	$1.42M	Sell	78,564 -600	-0.8%	-$9.91K	0.01%	466
2019 Q2	$1.24M	Buy	79,164 +400	+0.5%	+$7.87K	0.01%	465
2019 Q1	$1.79M	Buy	78,764 +600	+0.8%	+$13.5K	0.01%	455
2018 Q4	$1.82M	Hold	78,164	–	–	0.02%	437
2018 Q3	$2.58M	Buy	78,164 +1,664	+2%	+$62.2K	0.02%	407
2018 Q2	$3.37M	Buy	+76,500	New	+$2.96M	0.03%	412

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Carillon Tower Advisers's PETS Position: Q4 2020 in Review

Carillon Tower Advisers reduced its PetMed Express (PETS) stake by 4.7% in Q4 2020, selling an estimated $108K and leaving 71,413 shares worth $2.29M. The position accounts for 0.01% of the portfolio, ranked #458.

Carillon Tower Advisers first reported a position in PETS in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.37M in Q2 2018. 213 funds tracked by Wall St. Rank hold PETS as of Q4 2020.

Carillon Tower Advisers held 71,413 shares of PetMed Express worth $2.29M as of Q4 2020.
Carillon Tower Advisers sold 3,500 PetMed Express shares in Q4 2020, an estimated $108K.
PetMed Express made up 0.01% of Carillon Tower Advisers's portfolio in Q4 2020, its #458 holding.
Carillon Tower Advisers first reported a position in PetMed Express in Q2 2018 and has held it in 11 quarters since.
Carillon Tower Advisers's PetMed Express position peaked at $3.37M in Q2 2018.
213 funds tracked by Wall St. Rank held PetMed Express as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.